Literature DB >> 11497493

17-beta-estradiol suppresses IL-2 and IL-2 receptor.

R W McMurray1, K Ndebele, K J Hardy, J K Jenkins.   

Abstract

Interleukin-2 (IL-2) plays an important role in adaptive immune responses. These responses differ between females and males and may be due to the sex steroid estrogen. In this investigation we show that estrogen suppresses IL-2 production from activated peripheral blood T cells and CD4+ T cell lines at the transcriptional level. Suppression of IL-2 occurred at short term, high 17-beta-estradiol concentrations as well as longer term lower 17-beta-estradiol concentrations. In CD4+ Jurkat T cells, suppression of IL-2 was associated with decreased nuclear binding of two important IL-2 promoter transcription factors: NFkappaB and AP-1. The decreased nuclear binding of NFkappaB occurred in the setting of estrogen-induced increases in IkappaBalpha protein levels, an important inhibitor of NFkappaB nuclear translocation. 17-beta-Estradiol was also shown to inhibit IL-2 receptor (IL-2R) expression in activated peripheral blood T cells. Estrogen-induced suppression of IL-2 and its receptor may have many ramifications for our understanding of immune and autoimmune sexual dichotomies, immune responses during pregnancy, and potential therapeutic intervention with hormone agonists and antagonists. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497493     DOI: 10.1006/cyto.2001.0900

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  23 in total

1.  Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation.

Authors:  G Aleph Prieto; Yvonne Rosenstein
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Genetic and hormonal factors in female-biased autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; John W Kappler; Philippa Marrack
Journal:  Autoimmun Rev       Date:  2010-02-06       Impact factor: 9.754

3.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

4.  Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Authors:  Akihiro Inui; Hitoshi Ogasawara; Toshio Naito; Iwao Sekigawa; Yoshinari Takasaki; Yasuo Hayashida; Kenji Takamori; Hideoki Ogawa
Journal:  Clin Rheumatol       Date:  2007-02-16       Impact factor: 2.980

Review 5.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

6.  Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol.

Authors:  Elina El-Badry; Gladys Macharia; Daniel Claiborne; Kelsie Brooks; Darío A Dilernia; Paul Goepfert; William Kilembe; Susan Allen; Jill Gilmour; Eric Hunter
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Estrogenic activity of coumestrol, DDT, and TCDD in human cervical cancer cells.

Authors:  Kenneth Ndebele; Barbara Graham; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2010-05-04       Impact factor: 3.390

Review 8.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

Review 9.  Sex steroids and stem cell function.

Authors:  Rinki Ray; Nathan M Novotny; Paul R Crisostomo; Tim Lahm; Aaron Abarbanell; Daniel R Meldrum
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 10.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Authors:  Kathie Béland; Pascal Lapierre; Fernando Alvarez
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.